Abstract
Abstract Melanoma accounts for the vast majority of skin cancer-related deaths due to its ability to metastasize and therapeutic resistance. We aimed to identify expression-based signatures associated with melanoma patient survival by analyzing The Cancer Genome Atlas (TCGA) database to identify potential, prognostic biomarkers of cutaneous melanoma. Genes overexpressed in melanoma, compared with normal skin, as well as genes associated with the survival of melanoma patients were found using the online bioinformatics platform GEPIA2 (Gene Expression Profiling Interactive Analysis). The Metascape bioinformatics tool was then used for clustering of the genes based on processes and Protein-Protein Interaction (PPI) Enrichment Analysis. The genes from the 6 most significantly enriched pathways were selected to create gene signatures, which were then subjected to Kaplan-Meier survival analysis. Melanoma patients from the TCGA database (458) were placed into two groups (229 patients each): a high and a low expression group. There were 139 statistically significantly upregulated genes in melanoma (p<0.01), while 500 genes had expression levels that were significantly associated with the survival of melanoma patients. Overexpressed genes were found to belong to pigment-related pathways (pigmentation, cellular pigmentation, and pigment cell differentiation), while survival-associated genes were found to function in immune system-related pathways (adaptive immune response, lymphocyte activation, and immune response-regulating signaling pathways). Kaplan-Meier survival analysis showed that the most overexpressed genes in melanoma correlated with poorer survival, while higher expression of the most-significantly survival associated gene signatures correlated with better survival. Together, these gene signatures may serve as predictors of survival in melanoma patients. Citation Format: Stephanie Figueroa, Raj Tiwari, Jan Geliebter. Identification of gene expression signatures as potential novel biomarkers in malignant melanoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr 204.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
